AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $5.400M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| VRL | Ann: Trading Update | 20/04/18 | 14 | 2.5K | |||
|
|||||||
| VRL | PT 3.40 | 18/04/18 | 0 | 184 | |||
|
|||||||
| VRL | Ann: Employee Share Plan Buy-back - App 3C and Form 281 | 11/04/18 | 0 | 83 | |||
|
|||||||
| VRL | Ann: Change of Director's Interest Notice x 2 | 08/03/18 | 0 | 148 | |||
|
|||||||
| VRL | Ann: App 3B - Non-executive Directors Share Plan | 08/03/18 | 0 | 79 | |||
|
|||||||
| VRL | Ann: Change of Director's Interest Notice x 1 | 07/03/18 | 0 | 87 | |||
|
|||||||
See All Discussions
ASX News